Literature DB >> 27432822

Prognostic impact of Ki-67 labeling index in minimally invasive follicular thyroid carcinoma.

Yasuhiro Ito1, Mitsuyoshi Hirokawa, Akira Miyauchi, Hiroo Masuoka, Tomonori Yabuta, Mitsuhiro Fukushima, Minoru Kihara, Takuya Higashiyama, Kaoru Kobayashi, Akihiro Miya.   

Abstract

We investigated the prognostic impact of the Ki-67 labeling index (LI) in minimally invasive follicular thyroid carcinoma (FTC). We enrolled 192 patients (including four with distant metastasis at diagnosis) who were pathologically diagnosed as having minimally invasive FTC between 1998 and 2007 at Kuma Hospital. When the Ki-67 LI was higher than 5% in the hot area, we regarded it as a high Ki-67 LI. In a univariate analysis, patient age (≥45 years), high-frequent vascular invasion (≥4 in H&amp;E specimens), and high Ki-67 LI significantly predicted the disease-free survival (DFS) of the patients. Since none of the patients <45 years old showed a recurrence, we performed a multivariate analysis of variables other than patient age. In the multivariate analysis including the presence of vascular invasion, high Ki-67 LI was an independent predictor of carcinoma recurrence. However, in the multivariate analysis including high-frequent vascular invasion, only high-frequent vascular invasion independently affected the DFS. These findings suggest that the Ki-67 LI has a rather strong prognostic value for the DFS of patients, although its impact was less than those of patient age and high-frequent vascular invasion.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27432822     DOI: 10.1507/endocrj.EJ16-0277

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  5 in total

1.  Role of papillary thyroid carcinoma patients with Hashimoto thyroiditis: evaluation of oxidative stress and inflammatory markers.

Authors:  Natália Medeiros Dias Lopes; Hannah Hamada Mendonça Lens; Walison Augusto da Silva Brito; Julya Karen Bianchi; Poliana Camila Marinello; Rubens Cecchini; André Armani; Alessandra Lourenço Cecchini
Journal:  Clin Transl Oncol       Date:  2022-07-28       Impact factor: 3.340

2.  A six-gene panel to label follicular adenoma, low- and high-risk follicular thyroid carcinoma.

Authors:  Anello Marcello Poma; Riccardo Giannini; Paolo Piaggi; Clara Ugolini; Gabriele Materazzi; Paolo Miccoli; Paolo Vitti; Fulvio Basolo
Journal:  Endocr Connect       Date:  2018-01       Impact factor: 3.335

3.  Differential Expression of Glycolysis-Related Proteins in Follicular Neoplasms versus Hürthle Cell Neoplasms: A Retrospective Analysis.

Authors:  Hye Min Kim; Ja Seung Koo
Journal:  Dis Markers       Date:  2017-07-16       Impact factor: 3.434

Review 4.  Emerging Biomarkers in Thyroid Practice and Research.

Authors:  Shipra Agarwal; Andrey Bychkov; Chan-Kwon Jung
Journal:  Cancers (Basel)       Date:  2021-12-31       Impact factor: 6.639

5.  Prognostic Utility of the Ki-67 Labeling Index in Follicular Thyroid Tumors: a 20-Year Experience from a Tertiary Thyroid Center.

Authors:  L Samuel Hellgren; Adam Stenman; Johan O Paulsson; Anders Höög; Catharina Larsson; Jan Zedenius; C Christofer Juhlin
Journal:  Endocr Pathol       Date:  2022-03-19       Impact factor: 4.056

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.